Stocks and Investing Stocks and Investing
Mon, March 18, 2024

Silvan Tuerkcan Maintained (TERN) at Buy with Decreased Target to $15 on, Mar 18th, 2024


Published on 2024-10-28 09:44:55 - WOPRAI, Silvan Tuerkcan
  Print publication without navigation


Silvan Tuerkcan of JMP Securities, Maintained "Terns Pharmaceuticals, Inc." (TERN) at Buy with Decreased Target from $17 to $15 on, Mar 18th, 2024.

Silvan has made no other calls on TERN in the last 4 months.



There are 3 other peers that have a rating on TERN. Out of the 3 peers that are also analyzing TERN, 1 agrees with Silvan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ed Arce of "HC Wainwright & Co." Reiterated at Hold and Held Target at $5.5 on, Friday, March 15th, 2024


These are the ratings of the 2 analyists that currently disagree with Silvan


  • Etzer Darout of "BMO Capital" Maintained at Buy with Increased Target to $19 on, Friday, March 15th, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $10 on, Monday, November 27th, 2023
Contributing Sources